26.85
전일 마감가:
$27.88
열려 있는:
$27.73
하루 거래량:
2.00M
Relative Volume:
2.40
시가총액:
$2.51B
수익:
$4.72M
순이익/손실:
$-277.91M
주가수익비율:
-7.1984
EPS:
-3.73
순현금흐름:
$-203.56M
1주 성능:
-3.56%
1개월 성능:
-8.58%
6개월 성능:
-27.39%
1년 성능:
-47.08%
Crinetics Pharmaceuticals Inc Stock (CRNX) Company Profile
명칭
Crinetics Pharmaceuticals Inc
전화
858-450-6464
주소
6055 LUSK BLVD., SAN DIEGO, CA
CRNX을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
CRNX
Crinetics Pharmaceuticals Inc
|
26.85 | 2.67B | 4.72M | -277.91M | -203.56M | -3.73 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
![]()
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Crinetics Pharmaceuticals Inc Stock (CRNX) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-07-10 | 개시 | Goldman | Neutral |
2025-03-25 | 개시 | Stifel | Buy |
2025-02-11 | 개시 | TD Cowen | Buy |
2025-02-04 | 개시 | Wolfe Research | Peer Perform |
2025-01-22 | 업그레이드 | Jefferies | Hold → Buy |
2024-03-06 | 개시 | Citigroup | Buy |
2024-01-16 | 개시 | Morgan Stanley | Overweight |
2023-12-21 | 개시 | Jefferies | Hold |
2023-11-20 | 재개 | JP Morgan | Overweight |
2023-10-24 | 재개 | Cantor Fitzgerald | Overweight |
2023-08-31 | 개시 | Oppenheimer | Outperform |
2023-04-24 | 개시 | Piper Sandler | Overweight |
2023-03-30 | 개시 | Robert W. Baird | Outperform |
2021-11-30 | 개시 | JMP Securities | Mkt Outperform |
2021-11-23 | 개시 | Evercore ISI | Outperform |
2021-06-18 | 업그레이드 | JP Morgan | Neutral → Overweight |
2019-12-23 | 개시 | ROTH Capital | Buy |
2019-02-14 | 개시 | H.C. Wainwright | Buy |
2018-08-13 | 개시 | JP Morgan | Neutral |
2018-08-13 | 개시 | Leerink Partners | Outperform |
2018-08-13 | 개시 | Piper Jaffray | Overweight |
모두보기
Crinetics Pharmaceuticals Inc 주식(CRNX)의 최신 뉴스
Crinetics Pharmaceuticals: A Pipeline-Driven Inflection Point in Endocrine Therapeutics - AInvest
Crinetics 2025 Q2 Earnings Widening Losses Despite Revenue Surge - AInvest
How to read the order book for Crinetics Pharmaceuticals Inc.Free AI Trading Suggestions With Accuracy Focus - Newser
Transcript : Crinetics Pharmaceuticals, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Crinetics Pharmaceuticals (NASDAQ:CRNX) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Stifel lowers Crinetics stock price target to $58 from $60, keeps Buy rating - Investing.com Canada
Earnings call transcript: Crinetics Pharmaceuticals Q2 2025 results miss EPS forecast - Investing.com
Crinetics Pharmaceuticals Inc. (CRNX) Shares Soar 11.91% on 150% Revenue Surge - AInvest
Crinetics Pharmaceuticals Q2 Loss Widens, Revenue Rises; Shares up Pre-Bell - MarketScreener
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Shares Sold by Zurcher Kantonalbank Zurich Cantonalbank - Defense World
Crinetics Pharmaceuticals Inc (CRNX) Q2 2025 Earnings Call Highlights: Strategic Advancements ... By GuruFocus - Investing.com Canada
Crinetics Pharmaceuticals Inc (CRNX) Q2 2025 Earnings Call Highl - GuruFocus
Will breakout in Crinetics Pharmaceuticals Inc. lead to full recoveryRisk Adjusted Trade Signal Screening Tool - Newser
Decoding Crinetics Pharmaceuticals Inc (CRNX): A Strategic SWOT Insight - GuruFocus
Crinetics Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Why Crinetics Pharmaceuticals Inc. stock attracts strong analyst attentionSmart Risk Entry Zone Technical Analysis - Newser
Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Crinetics Pharma earnings missed by $0.13, revenue topped estimates - Investing.com Canada
Crinetics Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update | CRNX Stock News - GuruFocus
Crinetics Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update - The Manila Times
Crinetics Earnings: $1.2B War Chest Powers PALSONIFY Launch, FDA Decision Looms in September - Stock Titan
Crinetics Pharmaceuticals Q2 2025 Earnings Call Transcript - MarketBeat
Crinetics CRNX Q2 2025 Earnings Preview Downside Expected on Analyst EPS Downgrades - AInvest
Crinetics Pharmaceuticals, Inc. (CRNX)’ Oral Acromegaly Drug Nears FDA Decision After Strong Phase 3 Data - MSN
What are the technical indicators suggesting about Crinetics Pharmaceuticals Inc.Dynamic investment growth - Jammu Links News
Is it the right time to buy Crinetics Pharmaceuticals Inc. stockFastest-growing stock picks - Jammu Links News
What are analysts’ price targets for Crinetics Pharmaceuticals Inc. in the next 12 monthsStay informed with daily expert analysis - Jammu Links News
What institutional investors are buying Crinetics Pharmaceuticals Inc. stockFree Stock Movement Tracking - Jammu Links News
What is the risk reward ratio of investing in Crinetics Pharmaceuticals Inc. stockOver 200% growth - Jammu Links News
How strong is Crinetics Pharmaceuticals Inc. company’s balance sheetGet timely market insights for better trades - Jammu Links News
Real time alert setup for Crinetics Pharmaceuticals Inc. performanceConsistent Gain Plan with AI Support - Newser
When is Crinetics Pharmaceuticals Inc. stock expected to show significant growthInvest smarter with daily trading signals - Jammu Links News
Does Crinetics Pharmaceuticals Inc. stock perform well during market downturnsGet daily updates on market movers and shakers - Jammu Links News
Fibonacci Support Holding Strong in Crinetics Pharmaceuticals Inc.Trade Timing Strategy With Technical Data Explained - metal.it
Are Bears Losing Grip on Crinetics Pharmaceuticals Inc.Real Time Trade Opportunity Alerts Monitor Market Surges - metal.it
Earnings Preview: Crinetics Pharmaceuticals, Inc. (CRNX) Q2 Earnings Expected to Decline - Yahoo Finance
11 Best Future Stocks to Buy Now - Insider Monkey
What makes Crinetics Pharmaceuticals Inc. stock price move sharplyCapital Preserving Trade Plan Templates Shared - metal.it
Can Crinetics Pharmaceuticals Inc. Bounce Back From Weekly LowSmart Investment Tips Gaining Popularity Among Analysts - metal.it
Analyzing net buyer seller activity in Crinetics Pharmaceuticals Inc.Steady Return Plan Based on Data Analysis - Newser
Using data filters to optimize entry into Crinetics Pharmaceuticals Inc.Technical Screener for High Growth Stocks - Newser
Pattern recognition hints at Crinetics Pharmaceuticals Inc. upsideConsistent Return Setup with Exit Strategy - Newser
How does Crinetics Pharmaceuticals Inc. compare to its industry peersInvest confidently with proven investment plans - Jammu Links News
Should I hold or sell Crinetics Pharmaceuticals Inc. stock in 2025Best Dividend Updates For Beginners - jammulinksnews.com
What catalysts could drive Crinetics Pharmaceuticals Inc. stock higher in 2025Capitalize on emerging market opportunities - jammulinksnews.com
Is Crinetics Pharmaceuticals Inc. a growth stock or a value stockExplosive capital appreciation - Jammu Links News
Crinetics Pharmaceuticals Inc (CRNX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):